AB120885
PIT-1, PIP3/protein binding inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 351.76 g/mol, Purity >98%. PIP3/protein binding inhibitor. Specifically disrupts PIP3/Akt PH domain binding (IC50 = 31 μM); suppresses PI3K-PDK1-Akt-dependent phosphorylation. Reduces cell viability and induces apoptosis in PTEN-deficient U87MG glioblastoma cells (IC50 = 37 μM). 3,5-Dimethyl PIT-1 (ab120884) also available.
1 Images
- Chemical Structure
Lab
Chemical Structure - PIT-1, PIP3/protein binding inhibitor (AB120885)
2D chemical structure image of ab120885, PIT-1, PIP3/protein binding inhibitor
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 13:4540 PubMed35927244
2022
Synaptotagmin-13 orchestrates pancreatic endocrine cell egression and islet morphogenesis.
Applications
Unspecified application
Species
Unspecified reactive species
Mostafa Bakhti,Aimée Bastidas-Ponce,Sophie Tritschler,Oliver Czarnecki,Marta Tarquis-Medina,Eva Nedvedova,Jessica Jaki,Stefanie J Willmann,Katharina Scheibner,Perla Cota,Ciro Salinno,Karsten Boldt,Nicola Horn,Marius Ueffing,Ingo Burtscher,Fabian J Theis,Ünal Coskun,Heiko Lickert
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com